 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Apellis Pharmaceuticals Inc. (APLS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-02-18 Sale | 2020-02-20 4:07 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 35,637 | $40.66 | $1,449,122 | 1,027,430 (Indirect Direct) | View |
| 2020-02-14 Sale | 2020-02-19 4:30 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $42.35 | $105,875 | 669,544 (Indirect Direct) | View |
| 2020-02-12 Sale | 2020-02-14 4:49 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 107,473 | $41.86 | $4,499,121 | 1,008,681 (Direct) | View |
| 2020-02-10 Sale | 2020-02-12 4:38 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $44.5 | $222,500 | 35,417 (Indirect Direct) | View |
| 2020-01-27 Sale | 2020-01-28 5:08 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 3,000 | $40.47 | $121,401 | 19,042 (Indirect Direct) | View |
| 2020-01-13 Purchase | 2020-01-21 5:47 pm | Apellis Pharmaceuticals Inc. | APLS | Morningside Venture Investments Ltd 10% Owner | 540,540 | $37 | $19,999,980 | 12,556,342 (Direct) | View |
| 2020-01-15 Sale | 2020-01-17 4:11 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 35,638 | $42.11 | $1,500,788 | 1,001,793 (Indirect Direct) | View |
| 2020-01-15 Sale | 2020-01-17 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $41.47 | $103,675 | 669,544 (Indirect Direct) | View |
| 2019-12-18 Sale | 2019-12-20 5:11 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 136,000 | $29.12 | $3,960,868 | 224,728 (Indirect) | View |
| 2019-12-16 Sale | 2019-12-17 4:47 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 5,000 | $27.95 | $139,750 | 1,006,793 (Indirect Direct) | View |
| 2019-11-15 Sale | 2019-11-18 4:21 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 5,000 | $27.28 | $136,405 | 1,011,793 (Indirect Direct) | View |
| 2019-10-15 Sale | 2019-10-16 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 5,000 | $26.31 | $131,551 | 1,016,793 (Indirect Direct) | View |
| 2019-09-25 Sale | 2019-09-26 4:06 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 21,541 | $25.26 | $544,059 | 881,743 (Direct) | View |
| 2019-09-23 Sale | 2019-09-25 4:26 pm | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 42,460 | $24.82 | $1,053,995 | 903,284 (Direct) | View |
| 2019-09-16 Sale | 2019-09-17 7:29 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 5,000 | $26.59 | $132,949 | 1,021,793 (Indirect Direct) | View |
| 2019-08-29 Purchase | 2019-09-03 4:13 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 11,699 | $29.71 | $347,630 | 11,699 (Direct) | View |
| 2019-08-15 Sale | 2019-08-16 4:08 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 10,000 | $26.8 | $268,007 | 989,288 (Indirect Direct) | View |
| 2019-03-11 Purchase | 2019-03-13 3:32 pm | Apellis Pharmaceuticals Inc. | APLS | Morningside Venture Investments Ltd 10% Owner | 441,176 | $17 | $7,499,992 | 12,015,802 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-02-18 Exercise | 2020-02-20 4:07 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 30,637 | $2.14 | 1,027,430 (Direct) | View |
| 2020-02-18 Exercise | 2020-02-20 4:07 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 30,637 | $2.14 | 1,027,430 (Direct) | View |
| 2020-02-18 Exercise | 2020-02-20 4:07 pm | N/A 2020-05-12 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 30,637 | $2.14 | 1,027,430 (Direct) | View |
| 2020-02-18 Exercise | 2020-02-20 4:07 pm | N/A 2020-05-12 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 30,637 | $2.14 | 1,027,430 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-19 4:30 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $2.67 | 669,544 (Direct) | View |
| 2020-02-14 Exercise | 2020-02-19 4:30 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $2.67 | 669,544 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-14 4:49 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 117,206 | $2.14 | 1,008,681 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-14 4:49 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 117,205 | $2.14 | 1,008,681 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-14 4:49 pm | N/A 2020-05-12 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 117,206 | $2.14 | 1,008,681 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-14 4:49 pm | N/A 2020-05-12 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 117,205 | $2.14 | 1,008,681 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:13 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS See Remarks | 9,375 | $0 | 56,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:13 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS See Remarks | 56,250 | $44.33 | 56,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 9,375 | $0 | 56,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:12 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 56,250 | $44.33 | 56,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:09 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 11,688 | $0 | 70,125 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:09 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 70,125 | $44.33 | 70,125 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:07 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 34,375 | $0 | 206,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:07 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 206,250 | $44.33 | 206,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. See Remarks | 9,375 | $0 | 56,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:02 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. See Remarks | 56,250 | $44.33 | 56,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:58 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Celona Lucia See Remarks | 5,213 | $0 | 31,275 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:58 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Celona Lucia See Remarks | 31,275 | $44.33 | 31,275 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:54 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 2,500 | $0 | 15,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:54 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D VP | 15,000 | $44.33 | 15,000 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:50 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Lackner Thomas A. See Remarks | 2,725 | $0 | 16,350 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:50 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Lackner Thomas A. See Remarks | 16,350 | $44.33 | 16,350 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:46 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sadr Ahmad See Remarks | 2,725 | $0 | 16,350 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:46 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Sadr Ahmad See Remarks | 16,350 | $44.33 | 16,350 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:42 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks | 9,375 | $0 | 56,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:42 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Grossi Federico See Remarks | 56,250 | $44.33 | 56,250 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:38 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 6,375 | $0 | 35,417 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-12 4:38 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 7,505 | $2.67 | 35,417 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 4:38 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 38,250 | $44.33 | 35,417 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-12 4:38 pm | N/A 2023-12-31 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 7,505 | $2.67 | 35,417 (Direct) | View |
| 2020-01-27 Exercise | 2020-01-28 5:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 15,000 | $2.67 | 19,042 (Direct) | View |
| 2020-01-27 Exercise | 2020-01-28 5:08 pm | N/A 2023-12-29 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 15,000 | $2.67 | 19,042 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 09:22 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 30,637 | $2.14 | 122,548 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 09:22 am | N/A 2020-05-12 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 30,637 | $2.14 | 122,548 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-17 4:11 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 30,638 | $2.14 | 1,001,793 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-17 4:11 pm | N/A 2020-05-12 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 30,638 | $2.14 | 1,001,793 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-17 4:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $2.67 | 669,544 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-17 4:08 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 2,500 | $2.67 | 669,544 (Direct) | View |
| 2020-01-03 Option Award | 2020-01-03 4:40 pm | N/A 2029-12-31 | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 27,600 | $30.62 | 27,600 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 4:38 pm | N/A 2029-12-31 | Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director | 27,600 | $30.62 | 27,600 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 4:31 pm | N/A 2029-12-31 | Apellis Pharmaceuticals Inc. | APLS | O'Brien Stephanie Monaghan Director | 27,600 | $30.62 | 27,600 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 4:04 pm | N/A 2029-12-31 | Apellis Pharmaceuticals Inc. | APLS | Chan Gerald Director | 27,600 | $30.62 | 27,600 (Direct) | View |
| 2019-08-23 Exercise | 2019-08-26 4:10 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 37,505 | $2.67 | 478,200 (Direct) | View |
| 2019-08-23 Exercise | 2019-08-26 4:10 pm | N/A 2023-12-04 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 37,505 | $2.67 | 478,200 (Direct) | View |
| 2019-08-15 Exercise | 2019-08-16 4:08 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 10,000 | $2.14 | 989,288 (Direct) | View |
| 2019-08-15 Exercise | 2019-08-16 4:08 pm | N/A 2020-05-12 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 10,000 | $2.14 | 989,288 (Direct) | View |
| 2019-08-07 Exercise | 2019-08-09 08:48 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $2.67 | 22,505 (Direct) | View |
| 2019-08-07 Exercise | 2019-08-09 08:48 am | N/A 2023-12-31 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $2.67 | 22,505 (Direct) | View |
| 2019-06-27 Exercise | 2019-07-01 4:09 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 275,000 | $2.14 | 193,823 (Direct) | View |
| 2019-06-27 Exercise | 2019-07-01 4:09 pm | N/A 2020-05-12 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric CEO | 275,000 | $2.14 | 193,823 (Direct) | View |
| 2019-02-08 Option Award | 2019-02-12 4:18 pm | N/A 2029-02-07 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 40,000 | $13.85 | 40,000 (Direct) | View |
| 2019-02-08 Option Award | 2019-02-12 4:17 pm | N/A 2029-02-07 | Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS See Remarks | 85,000 | $13.85 | 85,000 (Direct) | View |
| 2019-02-08 Option Award | 2019-02-12 4:16 pm | N/A 2029-02-07 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene CFO | 95,000 | $13.85 | 95,000 (Direct) | View |
| 2019-02-08 Option Award | 2019-02-12 4:16 pm | N/A 2029-02-07 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal COO | 95,000 | $13.85 | 95,000 (Direct) | View |